The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
The FDA granted breakthrough therapy designation to privosegtor, a novel peptoid small molecule for the treatment of optic ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...
A study in mice by researchers at the School of Medicine indicates that brain injury can lead to brain tumors in susceptible individuals. For this study, they used mice that model people with ...
Reduced optic nerve head blood flow seems to be correlated with impaired pupil response in patients with glaucoma.
High axial myopia is linked to increased prevalence of nonglaucomatous, glaucoma-like, and glaucomatous optic neuropathies.
Prenatal opioid maintenance therapy exposure is associated with significant peripapillary retinal nerve fiber layer thinning in children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback